|
HS Code |
129021 |
| Product Name | Calcium 3-Methyl-2-Oxovalerate |
| Cas Number | 51828-94-1 |
| Molecular Formula | C6H9CaO3 |
| Molecular Weight | 168.22 |
| Appearance | White to off-white powder |
| Solubility In Water | Slightly soluble |
| Synonyms | Calcium 3-methyl-2-oxopentanoate |
| Chemical Class | Calcium salt of alpha-keto acid |
| Storage Temperature | 2-8°C |
| Purity | Typically ≥98% |
| Ec Number | 611-620-1 |
| Stability | Stable under recommended conditions |
| Usage | Research chemical |
As an accredited Calcium 3-Methyl-2-Oxovalerate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Opaque, white plastic bottle containing 100 grams of Calcium 3-Methyl-2-Oxovalerate; tamper-evident seal, hazard labeling, and batch identification. |
| Shipping | **Shipping Description:** Calcium 3-Methyl-2-Oxovalerate is shipped in tightly sealed containers to prevent moisture absorption and contamination. Packages comply with standard chemical transport regulations. Store and ship at ambient temperature, away from incompatible substances. Ensure labeling meets regulatory requirements and provide safety data sheets with the shipment. Handle with appropriate protective equipment. |
| Storage | Calcium 3-Methyl-2-oxovalerate should be stored in a tightly closed container, in a cool, dry, and well-ventilated area. Keep it away from moisture, heat, and incompatible substances such as strong acids and oxidizing agents. Store at room temperature and protect from light. Ensure proper labeling and prevent dust generation. Handle using appropriate personal protective equipment. |
Applications of Calcium 3-Methyl-2-Oxovalerate in Industrial ManufacturingCalcium 3-Methyl-2-Oxovalerate supports diverse specialty downstream sectors as a valued intermediate. Our direct supply chain enables integration into precise processes adhering to industry regulations. The following sections outline established manufacturing applications based on confirmed industrial demand and use patterns. 1. Pharmaceutical Synthesis of Antiepileptic Drug IntermediatesPharmaceutical manufacturers employ Calcium 3-Methyl-2-Oxovalerate as a direct precursor in the multi-step synthesis of antiepileptic drugs, including derivatives of valproic acid. The raw material enters as a key substrate in condensation reactions that construct core moieties under controlled cGMP conditions. Production environments demand traceability, validated specifications, and strict contaminant control. The use and ratio depend on targeted dosage form yields and batch synthesis volumes. Quality control measures focus on residual solvents, enantiomeric purity, and compliance with pharmacopeial limits for intermediates intended for final API production. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Special Nutrition Ingredients ManufacturingProducers of specialty nutrition supplements use Calcium 3-Methyl-2-Oxovalerate as a high-value source of branched-chain keto acid salts. This input is utilized in the compounding of medical foods for renal nutrition and specific metabolic management formulations. Stringent food safety and additive regulations apply throughout blending, with careful calibration of mineral and keto acid content to product label claims. Manufacturers rigorously control metal ion contamination and batch-to-batch homogeneity for consistency. Regulatory standards require adherence to ingredient traceability and published food additive specifications. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Industrial Peptide Synthesis for Research ChemicalsCustom peptide synthesis labs source Calcium 3-Methyl-2-Oxovalerate as a stable α-keto acid building block for side-chain analog construction and isotopic labeling applications. The compound is introduced during solid-phase peptide synthesis (SPPS) to introduce noncanonical amino acid derivatives, often for biochemical probe design or metabolic studies. Usage quantity aligns with the scale of peptide run and the number of sequence modifications. Certified lot release documentation for purity, trace metal levels, and molecular structure identity is critical for both QC and publication reproducibility. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Diagnostic Reagent ProductionDiagnostic reagent manufacturers utilize Calcium 3-Methyl-2-Oxovalerate as a specific substrate in enzyme activity test kits, particularly for measuring branched-chain amino acid metabolism in clinical biochemistry assays. The compound’s chemical stability and defined reaction endpoints enable reliable colorimetric or fluorometric readings in endpoint and kinetic assay formats. Accurate metering and QC release for contaminant limits underpin each batch. Kit production requires critical documentation for CE-IVD or FDA device listing depending on regional regulatory scope. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Calcium 3-Methyl-2-Oxovalerate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Working at the chemical manufacturing level means less daylight between raw material and end use. Our facility handles the process right from selection of reactants through to the final checks. On the busy floor, every batch of Calcium 3-Methyl-2-Oxovalerate runs under vigilant eyes—delivered with the accuracy that end-users count on.
Calcium 3-Methyl-2-Oxovalerate, produced under rigorous process control, finds its primary roots in pharmaceutical and biochemical synthesis pipelines. We've learned to appreciate its significant role as a key intermediate in the construction of branched-chain amino acid derivatives. When our early teams built out initial reaction systems, the focus landed on consistency in both yield and purity. This white, odorless powder provides a reliable feedstock, far more predictable in energy and reactivity profile than similar alpha-keto acid calcium salts.
We manufacture Calcium 3-Methyl-2-Oxovalerate under the identification of our internal code: C3MOVA, batch-marked for traceability. Each lot follows strict batch synthesis in glass-lined reactors, where we closely regulate reaction temperature and pH to avoid unwanted side-products. By controlling oxidation steps tightly, we've minimized impurity levels. Product is dried under vacuum, then milled to a free-flowing, fine-mesh powder that pours cleanly into blending and downstream environments.
Formulated as a calcium salt of 3-methyl-2-oxovaleric acid, our product achieves a chemical purity exceeding 98 percent by HPLC analyses, with calcium content analyzed via ICP-OES. Typical particle size distribution allows for direct introduction into tablet blends or solution preparation, eliminating the need for secondary grinding. Loss on drying stays below 1 percent, a result achieved through multi-stage control of our drying process, not by excessive heating but by efficient vacuum conditions.
From daily interaction with R&D and formulation teams, it's clear that utility drives demand. Chemists looking to synthesize specialized alpha-keto acids or build custom nutritional formulations pull Calcium 3-Methyl-2-Oxovalerate from inventory regularly. In pharmaceutical development, it acts as a precursor for certain modified amino acid derivatives, an area alive with research around metabolic disorders and targeted supplementation. This product distinctively serves as a calcium source that doubles as an active intermediate in metabolic conjugation.
Nutritional manufacturers use our grade specifically to formulate performance blends catering to athletes or metabolic syndrome patients, leveraging both the organic acid moiety and the bound calcium. We have collaborated with global pilot plants that demand lot-to-lot consistency, as small shifts in reactivity or trace metal content can disrupt complex syntheses downstream. No two application environments appear exactly alike, but the lessons from process troubleshooting—where even a small rise in residual solvents could lead to precipitation or clogging during container unloading—remind us to fine-tune every drying and milling step.
Manufacturers weigh their choices carefully. Chemists familiar with regular calcium salts often remark on the difference in reaction kinetics and solubility profiles brought by our Calcium 3-Methyl-2-Oxovalerate. Compared with more common salts like Calcium Lactate or Calcium Gluconate, this product handles differently. For starters, the oxovalerate backbone opens alternative conjugation pathways, supporting synthesis routes that call for greater chemical specificity. Manufacturing such a uniquely functional intermediate means we adapt our equipment cleaning routines and reagent purity controls, addressing the persistent challenge of cross-contamination.
In proteins and peptide synthesis labs, accuracy in reactant identity can make or break months of work. General-purpose calcium sources often drag in variable residuals, or even non-volatile contaminants, jeopardizing yields when used as chemical building blocks. Calcium 3-Methyl-2-Oxovalerate, as we deliver it, passes stringent in-house and third-party heavy metal scrutiny—especially in regard to lead and arsenic content—thanks to repeated process adaptation, not just surface washing or filtration. Only chemically bonded water remains in our final lots, because residual moisture can spark hydrolysis during storage.
Our teams have witnessed, during scale-up trials, that minor lapses in end-product drying invite everything from caking to loss of chemical activity. Particle morphology and hydration level, which appear trivial at first glance, actually determine the rate of dissolution and material flow during automated dispensing. We act on these learnings by running finer particle analysis—not just relying on digital sieving—evaluating batch stability at simulated warehouse humidity. Our packaging team uses lined, moisture-barrier drums sealed straight off the line, rather than simply relying on bulk liners or cartons prefilled with desiccant pouches.
Comparing our hands-on process to some bulk suppliers, it’s clear many facilities try to hit the same purity numbers with different philosophies. Some try to shortcut drying with higher heat, inviting trace decomposition. Others skip thorough raw material analysis, passing on undetected trace organics. Our staff, drawn largely from science and technical backgrounds, hold routine troubleshooting cycles during campaign cleaning—incorporating both observed failures and customer returns data. These cycles have shaped our particle sizing decisions and led to adoption of rapid ion chromatography to catch false positive chloride tests.
Years of working in partnership with formulation chemists have sharpened our sense of how real-world conditions can complicate otherwise simple reactions. Bumping seen during solvent switch or erratic yield shifts on otherwise identical recipes often trace back to minute differences at the raw material level. Our technical support team routinely works alongside client labs, not only to replace a bad lot, but to jointly unravel root causes. The calcium salt form, in particular, offers advantages in stability and chemical compatibility—but is never one-size-fits-all.
Delivering on this requires more than hitting a minimum purity number; it demands real transparency in both process and documentation. As regulatory expectations rise, especially for food and drug intermediates, we've expanded our monitoring programs beyond the usual heavy metals and loss-on-drying metrics. Microbial contamination, packaging migration, and storage stability now surface in our QA cycles, even though these aren’t always specified by clients. We know firsthand how even trace mold or plasticizer ingress can lead to rejected batches at the customer’s end. This same deliberate focus shows up in requalification audits, where tracking product back from each end user highlights areas for ongoing process improvement.
Years ago, a batch of Calcium 3-Methyl-2-Oxovalerate that drifted just a few percent above normal moisture content led to clumping in a client’s pill press, a detail missed during a rushed production campaign. After client feedback, we traced the problem to subtle humidity shifts during transfer into final hoppers, bringing about changes in how we sequence drying and packing steps. Sharing these kinds of real outcomes, inside meetings and with our client contacts, has deepened our understanding of how tweaks in our environment ripple into customer processes.
Working inside a chemical manufacturing plant sometimes means learning from failure as much as from published literature. Most published data sheets do not anticipate a blocked feeder or a false color reaction caused by trace side-products. Our in-house team maintains an open log of incident-based corrective actions, not just final pass/fail reports, so we stay ahead of surprises that can catch a downstream formulator off guard. Colleagues from QC, production, and packing all contribute to a rolling improvement plan with links to actual customer recall cases and lessons learned from repeated root-cause analyses.
Our sector faces a wave of evolving compliance targets in every geography, prompted by closer scrutiny of food and pharma intermediates. Calcium 3-Methyl-2-Oxovalerate seldom appears as an end-use supplement, yet downstream exposure means stricter ingredient testing and batch specific documentation. To preempt gaps, we invest in real-time documentation at each production checkpoint, full reagent source tracing, and routine stability evaluation protocols. We run comparative stability data on retained samples, extending shelf-life studies under both accelerated and ambient temperature swings.
In the last few years, collaborative audits with users from Japan and Europe have prompted upgrades to recordkeeping layouts and allergen segregation routines. Chemists on their teams flagged subtle issues, from packaging overlap to chance contamination during rail or sea transport—issues rarely raised in less demanding markets. Rather than waiting for formal recalls or market rejections, we model these “what-if” scenarios with process FMEA assessments involving both plant and quality staff.
A major criticism from technical buyers is the industry’s occasional tendency to treat specialty chemicals like commodity items. Our approach to Calcium 3-Methyl-2-Oxovalerate breaks with this pattern, deriving from direct handling and iterative feedback at scale, not just upscaling lab-grade synthesis. Packing staff, chemists, and process supervisors all interact with real product, under real environmental and time constraints. This grounded experience is what filters back into each process upgrade—we do not frame improvements around abstract ideas of quality, but on lived results at lab bench, granulator, and pressed tablet.
Routine comparison against benchmark lots demonstrates that our product’s lower variance in calcium content and minimal trace organics lead to tighter control in batch-to-batch end product results. Peers in contract manufacturing appreciate that ability to anticipate—and troubleshoot—variations due to minor product shiftings. We log changes into client-facing reports after every major campaign, so feedback never lags, and improvements move forward rapidly.
Manufacturing any calcium organic acid salt, including the 3-methyl-2-oxovalerate, isn’t just about technical specs—it’s about the sustainability and stewardship exemplified through daily choices on the floor. Energy input per kilogram, management of solvent emission, and water handling, all require ongoing adjustment. We have shifted toward closed-loop water chilling and solvent recovery, reducing footprint even as output has risen. Worker training sessions focus on safe handling of both reactants and byproducts—an approach grounded in our own incident data, not just external regulation.
We partner with regional environmental agencies, investing in technology upgrades that reduce both ambient workplace exposure and local waterway discharge risk. Unlike larger facilities run on generic legacy protocols, our teams regularly reexamine whether existing abatement systems meet current emission profiles. These pivots, based on emission analysis results from actual operational data, feed into yearly capex planning and community engagement. The goal stays the same: consistent, high-quality chemical output that honors both customer commitment and environmental standards.
Experienced manufacturers recognize that Calcium 3-Methyl-2-Oxovalerate excels not just in its base chemical identity, but in predictability at scale, support for downstream synthesis, and close alignment with regulatory and environmental priorities. Our approach, grounded in decades of iterative troubleshooting and open technical exchange, results in a product that stands apart—meeting the nuanced demands of modern research, health, and nutrition sectors.
This difference owes little to abstract notions, and everything to the practical learning earned batch by batch, challenge by challenge, on the production floor.